Total investments 5
Average round size 
$77M
The average size of a deal this fund participated in
Portfolio companies 4
Rounds per year 0.15
Lead investments 2
Follow on index
0.20How often the fund supports its portfolio startups at next rounds
Exits 2
Key employees Soon
Boston, Massachusetts, United States Related Funds
Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Vertex Pharmaceuticals:
Typical Co-investors
Vertex Pharmaceuticals is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Vertex Pharmaceuticals:
There are no funds here. If we find new data, we will add it here.
Look at other 50 related and similar funds Collapse list ↓
| Fund Name | Location |
| Bluegrass Growth Fund Partners | New York, New York, United States |
| codecentric AG | Düsseldorf, Germany, Nordrhein-Westfalen |
| Communicade | New York, New York, United States |
| DFGS | Beijing, Beijing, China |
| eHUB | Alberta, Canada, Edmonton |
| Elementum Ventures | California, Menlo Park, United States |
| Exact Sciences | Madison, United States, Wisconsin |
| Fitz Gate Ventures | Houston, Texas, United States |
| Fluxus Ventures | France, Ile-de-France, Paris |
| Future Africa | - |
| HashtagOne | California, Los Angeles, United States |
| OakStone Ventures | California, Palo Alto, United States |
| Platinum Asset Management | Australia, New South Wales, Sydney |
| Round One Investors | - |
| Sleeping Bear Capital | California, San Francisco, United States |
| Staidson Hongkong Investment | China, Hong Kong, Hong Kong Island |
| T.H.E. Capital & Lab | Beijing, Beijing, China |
| Will Hunting Capital | Beijing, Beijing, China |
| X-Ventures Venture Fund Management Company | Budapest, Hungary |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Arbor Biotechnologies | $215M | 09 Nov 2021 | Cambridge, Massachusetts, United States | ||
Kymera Therapeutics | $102M | 12 Mar 2020 | Cambridge, Massachusetts, United States | ||
Genomics | $9M | 09 Dec 2018 | Oxford, England, United Kingdom | ||
Genomics | $34M | 30 Aug 2018 | Oxford, England, United Kingdom | ||
CRISPR Therapeutics | $29M | 30 Apr 2015 | Cambridge, Massachusetts, United States |
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
To post a comment or write a complain, please sign in with LinkedIn
Review
- No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Do you represent Vertex Pharmaceuticals?
Get access to manage this page
Found incorrect info? Let us know!
Total investments 5
Average round size 77M
Rounds per year 0.15
Peak activity year 2018
Lead investments 2
Follow on index 0.20
Exits 2
Group Appearance index 1.00
Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Arbor Biotechnologies | $215M | 09 Nov 2021 | Cambridge, Massachusetts, United States | ||
Kymera Therapeutics | $102M | 12 Mar 2020 | Cambridge, Massachusetts, United States | ||
Genomics | $9M | 09 Dec 2018 | Oxford, England, United Kingdom | ||
Genomics | $34M | 30 Aug 2018 | Oxford, England, United Kingdom | ||
CRISPR Therapeutics | $29M | 30 Apr 2015 | Cambridge, Massachusetts, United States |
